Shopping Cart
- Remove All
- Your shopping cart is currently empty
Regdanvimab (CT-P59) is a human monoclonal antibody targeting the receptor-binding domain of the SARS-CoV-2 spike protein, inhibiting the virus's cell entry by blocking its interaction with the ACE2 receptor. It is utilized in COVID-19 research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Regdanvimab (CT-P59) is a human monoclonal antibody targeting the receptor-binding domain of the SARS-CoV-2 spike protein, inhibiting the virus's cell entry by blocking its interaction with the ACE2 receptor. It is utilized in COVID-19 research [1]. |
Cas No. | 2444308-95-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.